TW201642882A - Nutrient tonic containing bee larvae - Google Patents

Nutrient tonic containing bee larvae Download PDF

Info

Publication number
TW201642882A
TW201642882A TW105111807A TW105111807A TW201642882A TW 201642882 A TW201642882 A TW 201642882A TW 105111807 A TW105111807 A TW 105111807A TW 105111807 A TW105111807 A TW 105111807A TW 201642882 A TW201642882 A TW 201642882A
Authority
TW
Taiwan
Prior art keywords
strong
agent
bees
bee
fatigue
Prior art date
Application number
TW105111807A
Other languages
Chinese (zh)
Inventor
結石倫世
福島忍
生田智樹
Original Assignee
山田養蜂場本社股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 山田養蜂場本社股份有限公司 filed Critical 山田養蜂場本社股份有限公司
Publication of TW201642882A publication Critical patent/TW201642882A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L21/00Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
    • A23L21/20Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods

Abstract

Disclosed are a restorative tonic including bee larvae, a sexual-function-improving agent including bee larvae, a male-menopausal-symptom-improving agent including bee larvae, and an anti-fatigue agent including bee larvae.

Description

含有蜂子的滋養強壯劑 Nourishing strongener containing bees

本發明係關於強壯強精劑、性功能改善劑、男性更年期症狀改善劑及抗疲勞劑。 The invention relates to a strong and strong sperm, a sexual function improving agent, a male menopausal symptom improving agent and an anti-fatigue agent.

男性所面臨關於老化之1個問題,係男性更年期的發現。目前推測約有40%之40代~60代的男性經歷過某程度的男性更年期。 One problem that men face about aging is the discovery of male menopause. It is currently estimated that about 40% of men from 40 to 60 generations have experienced some degree of male menopause.

進入男性更年期,將會強烈感到各種症狀(例如,抑鬱、沮喪、煩躁、不安、神經過敏、疲勞感、失去生氣、筋肉炎、關節炎、筋力降低、發熱、發汗、記憶力降低、睡眠障礙、集中力降低、肉體消耗感、勃起障礙(ED)、性慾降低、射精感的消失等)。作為確認是否係男性更年期障礙之方法,有藉由血液檢查測定血中睪固酮濃度及問卷調查之方法。目前指摘出男性更年期障礙之發病與壯年期男性面對工作及家庭中各種壓力極度相關,近年來,疑似進入更年期障礙之中高年男性有增加之傾向。 Entering male menopause, you will feel a variety of symptoms (eg depression, depression, irritability, restlessness, nervousness, fatigue, loss of life, sarcoma, arthritis, decreased strength, fever, sweating, memory loss, sleep disorders, concentration Reduced power, physical exhaustion, erectile dysfunction (ED), decreased libido, loss of ejaculation, etc.). As a method for confirming whether or not it is a male menopausal disorder, there is a method of measuring blood testosterone concentration by blood test and a questionnaire. At present, it is pointed out that the incidence of menopausal disorders in men is extremely related to the various stresses in men and women in work and family. In recent years, there has been a tendency for males in high years to increase into menopausal disorders.

男性更年期障礙係以增齡性之雄激素降低為背景,會出現與女性更年期障礙類似之自律神經失調症狀及精神神經症狀,且在大多數之情況會顯示進一步合併男性功能低下之疾病狀態(奥山 明彦 著書 男性更年期 LOH症候群 I男性更年期 D.從心療內科的視點來看 24頁 ((株)南山堂)2007.)。另一方面,睪固酮為首之性荷爾蒙的分泌,係經由下視丘-腦下垂體-精巢系以負回饋調整包含睪固酮之荷爾蒙的分泌(奥山 明彦 著書 男性更年期障礙 LOH症候群 II男性更年期的診斷 C.荷爾蒙測定及評估 65頁 ((株)南山堂)2007.)。因此,只根據睪固醇之測定值難以判斷男性更年期障礙。 Male climacteric disorder is based on the age-reducing androgen reduction, and there are autonomic dysfunction symptoms and neuropsychiatric symptoms similar to female climacteric disorders, and in most cases it will show further complication of male dysfunction (Okuyama Akiko) Book male menopause LOH syndrome I male menopause D. From the point of view of cardiotherapy, 24 pages (Nanshan Hall, Inc.) 2007.). On the other hand, the secretion of sex hormones, which is the first of the sex hormones, is regulated by the hypothalamic-pituitary-seed nest with negative feedback to regulate the secretion of hormones containing steroids (Osama Akira's book menopausal disorder LOH syndrome II male menopause diagnosis C. Hormone determination and evaluation, 65 pages (Nanshan Hall, 2007). Therefore, it is difficult to judge male menopausal disorders based only on the measured values of steroids.

一般而言,自覺活力降低,且發現血液中之游離睪固酮有降低傾向之受試者,將被診斷為增齡男性性腺功能低下症候群(LOH症候群),為了維持QOL而適應雄激素替代療法。然而,相對於女性之荷爾蒙替代療法已國際普及,對於男性之治療僅有在ED使用PDE5抑制劑等普及以外,並非醫療之對象。 In general, subjects with reduced self-consciousness and a tendency to reduce free steroids in the blood will be diagnosed as age-related male hypogonadism syndrome (LOH syndrome) and adapted to androgen replacement therapy in order to maintain QOL. However, hormone replacement therapy has been popularized internationally with respect to women, and treatment for men is not only medically popular except for the widespread use of EDs using PDE5 inhibitors.

例如,專利文獻1~3已報告使睪固醇上升之各種成分。 For example, Patent Documents 1 to 3 have reported various components for raising steroids.

專利文獻1報告黨參屬植物所含川黨參苷(Tangshenoside)類、輪葉黨參皂苷(Lancemaside-A)及紫丁香苷(Syringin)對於血中睪固醇之低下具有抑制作用。 Patent Document 1 reports that the Tangshinoside, Lancemaside-A, and Syringin contained in the Codonopsis genus have an inhibitory effect on blood steroids.

專利文獻2報告香葉基香葉醇具有睪固醇增強作用。 Patent Document 2 reports that geranylgeranol has a steroid enhancing effect.

專利文獻3報告黑醋相關材料及將該素材與特定素材組合可顯著促進睪固醇的分泌。 Patent Document 3 reports black vinegar-related materials and combining the materials with specific materials can significantly promote the secretion of steroids.

然而,雄激素替代療法亦有產生副作用之可能性,特別係關於前列腺腫瘤標誌物之前列腺特異性抗原(PSA)需要特別注意,因此目前需要一種無雄激素效應之更年期症狀緩和劑。 However, androgen replacement therapy also has the potential to cause side effects, particularly prostate-specific antigens (PSAs) for prostate tumor markers that require special attention, and therefore there is a need for a menopausal symptom-lowering agent that has no androgenic effects.

此外,作為ED治療藥係使用PDE5抑制劑之「西地那非」。然而,雖然西地那非為短暫性的,但副作用及藥物相互作用已被報告。例 如,對於硝酸甘油等之硝酸劑的血壓下降作用,由於西地那非會促進該作用,因此禁忌將其等併用,此外,其對於眼腈之作用,可認為有青視症、複視、紅視症等。 In addition, "sildenafil" which is a PDE5 inhibitor is used as an ED therapeutic drug system. However, although sildenafil is transient, side effects and drug interactions have been reported. example For example, for the blood pressure lowering action of a nitric acid agent such as nitroglycerin, since sildenafil promotes the action, it is contraindicated and used together, and in addition, its effect on the eye nitrile may be considered to have blue vision, double vision, Red vision and so on.

在此,蜂子從古代以來在各國及地域被作為蛋白質等營養源而食用。近年,目前已習知有將蜂子粉碎乾燥後所得之粉末作為原料之健康食品。此健康食品,富含蜂子所具有的蛋白質、胺基酸、維生素及礦物質。且蜂子如專利文獻4所揭示,雖然已知其具有抗氧化作用,但仍有多數其他作用不為人知。 Here, the bee has been eaten as a nutrient source such as protein in various countries and regions since ancient times. In recent years, it has been known to use a powder obtained by pulverizing and drying a bee as a raw material. This healthy food is rich in protein, amino acids, vitamins and minerals found in bees. Further, as disclosed in Patent Document 4, the bee is known to have an antioxidant effect, but most of the other effects are not known.

【先前技術文獻】[Previous Technical Literature] 【專利文獻】[Patent Literature]

【專利文獻1】日本特開2006-306889號公報 [Patent Document 1] Japanese Patent Laid-Open Publication No. 2006-306889

【專利文獻2】日本特許第5382512號公報 [Patent Document 2] Japanese Patent No. 5382212

【專利文獻3】日本特開2013-181031號公報 [Patent Document 3] Japanese Patent Laid-Open Publication No. 2013-181031

【專利文獻4】日本特許第5405067公報 [Patent Document 4] Japanese Patent No. 5405067

本發明之目的係提供一種不會使雄激素上升,且安全性高之強壯強精劑、性功能改善劑、男性更年期症狀改善劑及抗疲勞劑。 An object of the present invention is to provide a strong and strong sperm, a sexual function improving agent, a male menopausal symptom improving agent, and an anti-fatigue agent which do not cause an androgen to rise and which are highly safe.

本發明者為了達成上述目的而重複銳意研究之結果,得到關 於蜂子具有強壯強精作用、性功能改善作用、男性更年期症狀之改善作用及抗疲勞作用,並且,得到蜂子可不使雄激素上升,具有高安全性之研究成果。 The present inventors repeated the results of the intensive research in order to achieve the above object, and obtained the off The bee has strong and strong effects, sexual function improvement, men's menopausal symptoms and anti-fatigue effects, and the results of high safety are obtained by the fact that the bees can not increase androgen.

本發明係根據此等知識為基準,更進一步反覆研究而完成,提供以下之強壯強精劑、性功能改善劑、男性更年期症狀改善劑及抗疲勞劑。 The present invention is based on such knowledge and is further researched and repeated, and provides the following strong and strong sperm, sexual function improving agent, male menopausal symptom improving agent and anti-fatigue agent.

項1.一種含有蜂子的強壯強精劑。 Item 1. A strong and strong agent containing bees.

項2.一種含有蜂子的性功能改善劑。 Item 2. A sexual function improving agent containing bees.

項3.一種含有蜂子的男性更年期症狀改善劑。 Item 3. A male menopausal symptom improving agent containing bees.

項4.一種含有蜂子的抗疲勞劑。 Item 4. An anti-fatigue agent containing bees.

項5.一種含有蜂子的提升活力劑。 Item 5. An enhancer containing bees.

項6.如項1所記載之強壯強精劑、如項2所記載之性功能改善劑、如項3所記載之男性更年期症狀改善劑、如項4所記載之抗疲勞劑、及如項5所記載之提升活力劑,其中,前述蜂子係以蛋白質分解酵素處理者。 Item 6. The strong and strong agent according to Item 1, the sexual function improving agent according to Item 2, the male menopausal symptom improving agent according to Item 3, the anti-fatigue agent according to Item 4, and the item 5 as described in Item 5 The activator, wherein the bee is treated with a protein degrading enzyme.

項7.一種含有蜂子的強壯強精用、性功能改善用、男性更年期症狀改善用、抗疲勞用及/或提升活力用組成物。 Item 7. A composition containing strong and strong use of bees, improvement of sexual function, improvement of male menopausal symptoms, use of anti-fatigue and/or vitality.

項8.一種含有蜂子的強壯強精用、性功能改善用、男性更年期症狀改善用、抗疲勞用及/或提升活力用食品組成物。 Item 8. A food composition containing strong and strong use of bees, improvement of sexual function, improvement of male menopausal symptoms, use of anti-fatigue and/or vitality.

項9.如項7或8所記載之組成物,其中,前述蜂子係以蛋 白質分解酵素處理者。 Item 9. The composition according to Item 7 or 8, wherein the bee is an egg White matter decomposing enzyme processor.

項10.一種強壯強精方法、性功能改善方法、男性更年期症狀改善方法、疲勞改善方法及提升活力方法,其係含有將蜂子之有效量對於哺乳動物投藥之步驟。 Item 10. A method for strengthening and strengthening, a method for improving sexual function, a method for improving male menopausal symptoms, a method for improving fatigue, and a method for improving vitality, comprising the step of administering an effective amount of a bee to a mammal.

項11.如項10所記載之方法,其中,前述蜂子係以蛋白質分解酵素處理者。 Item 11. The method according to Item 10, wherein the bee is treated with a proteolytic enzyme.

項12.一種強壯強精劑、性功能改善劑、男性更年期症狀改善劑、抗疲勞劑、及提升活力劑之製造中蜂子的使用。 Item 12. The use of a strong and strong sperm, a sexual function improving agent, a male menopausal symptom improving agent, an anti-fatigue agent, and a booster in the manufacture of a booster.

項13.如項12所記載之使用,其中,前述蜂子係以蛋白質分解酵素處理者。 Item 13. The use according to Item 12, wherein the bee is treated with a proteolytic enzyme.

由於蜂子具有強壯強精作用之改善作用、性功能改善作用、男性更年期症狀之改善作用及抗疲勞作用,因此可適宜作為強壯強精劑、性功能改善劑、男性更年期症狀改善劑及抗疲勞劑之有效成分。進一步,蜂子可不使雄激素上升,具有高安全性。 Because the bee has the effect of strengthening and strengthening the body, improving the sexual function, improving the menopausal symptoms and anti-fatigue effect, it can be suitable as a strong and strong agent, a sexual function improving agent, a male menopausal symptom improving agent and anti-fatigue. The active ingredient of the agent. Further, the bee can increase the androgen and has high safety.

【圖1】表示攝取試驗食品前後之(a)AMS分數(合計)、(b)AMS分數(性因素)、(c)AMS分數(身體因素)之圖表。平均值±SE *p<0.05 **p<0.01 Fig. 1 is a graph showing (a) AMS score (total), (b) AMS score (sex factor), and (c) AMS score (physical factor) before and after ingestion of test food. Mean ± SE * p < 0.05 ** p < 0.01

【圖2】表示攝取試驗食品前後之IIEF5之圖表。平均值±SE *p<0.05 **p<0.01 Fig. 2 is a graph showing IIEF5 before and after ingestion of test foods. Mean ± SE * p < 0.05 ** p < 0.01

【圖3】表示攝取試驗食品前後之早晨勃起次數之圖表。平均值±SE *p<0.05 **p<0.01 Fig. 3 is a graph showing the number of erections in the morning before and after ingestion of the test food. Mean ± SE * p < 0.05 ** p < 0.01

【圖4】表示攝取試驗食品前後之疲勞感VAS之圖表。平均值±SE *p<0.05 **p<0.01 Fig. 4 is a graph showing the fatigue feeling VAS before and after ingestion of the test food. Mean ± SE * p < 0.05 ** p < 0.01

【圖5】表示攝取試驗食品前後之SDS之圖表。平均值±SE *p<0.05 **p<0.01 Fig. 5 is a graph showing SDS before and after ingestion of test foods. Mean ± SE * p < 0.05 ** p < 0.01

【圖6】表示攝取試驗食品前後之(a)TT、(b)FT之圖表。平均值±SE p<0.05 Fig. 6 is a graph showing (a) TT and (b) FT before and after ingestion of test foods. Mean ± SE p < 0.05

以下,詳細說明本發明。 Hereinafter, the present invention will be described in detail.

本發明之強壯強精劑、性功能改善劑、男性更年期症狀改善劑及抗疲勞劑之特徵係含有蜂子。 The strong and strong sperm, the sexual function improving agent, the male menopausal symptom improving agent and the anti-fatigue agent of the present invention are characterized by containing bees.

本發明之強壯強精劑、性功能改善劑、男性更年期症狀改善劑及抗疲勞劑,可不使雄激素上升,因此具有高安全性。。 The strong and strong essence agent, the sexual function improving agent, the male menopausal symptom improving agent and the anti-fatigue agent of the present invention have high safety without increasing the androgen. .

雄激素,係亦稱為男性荷爾蒙之類固醇激素的總稱,其中,除了代表性之睪固酮以外,亦包含雙氫睪固酮、脫氫表雄酮、雄甾酮、雄烯二酮、表雄酮等。 Androgens, also known as hormonal hormones for male hormones, include, in addition to the representative steroids, dihydroguanosterone, dehydroepiandrosterone, androstenone, androstenedione, epiandrosterone, and the like.

在此之蜂子,係指蜂的幼蟲及蛹。蜂之種類並無特別限制,可廣泛使用:日本蜜蜂、西方蜜蜂等之蜜蜂、非洲蜂化蜜蜂、胡蜂(包含黑 胡蜂)、馬蜂、熊蜂等、習知的蜂。且較佳係使用蜜蜂,而以容易獲得之觀點而言更佳係使用西方蜜蜂。又,雖然可不論雄或雌,但較佳係雄蜂。 The bee here refers to the larvae and mites of the bees. There are no special restrictions on the types of bees. They can be widely used: Japanese honey bees, western honey bees, bees, African bee-like bees, wasps (including blacks). Vespa, bees, bumblebees, etc., known bees. It is preferable to use bees, and it is preferable to use western honey bees from the viewpoint of easy availability. Further, although it may be male or female, it is preferably a drone.

幼蟲及蛹,只要係由卵孵化者即可,並無特別限制。其中較佳係使用孵化後經過16~23日之蜂的幼蟲及蛹,更佳係使用孵化後經過18~21日之蜂的幼蟲及蛹。 The larvae and mites are not particularly limited as long as they are hatched by the eggs. Among them, it is preferred to use larvae and pupa of bees that have been hatched for 16 to 23 days after hatching, and it is preferable to use larvae and pupa of bees that have been hatched for 18 to 21 days after hatching.

蜂子可在體內積蓄營養素。特別地,雄蜂從古代即被作為漢方之素材使用,其含有必須胺基酸之各種胺基酸不僅均衡地包含存在,而且還富含蛋白質、脂質、醣類、維他命B群、葉酸、菸鹼酸、泛酸等之維生素群、及鋅、硒(Selenium)等之礦物。蜂子的生理活動及藥理作用,已知有抗菌作用、抗炎症作用、抗病毒作用、抗原蟲作用、消除耳鳴作用等。 Bees can accumulate nutrients in the body. In particular, drones have been used as materials for the Han Dynasty since ancient times, and their various amino acids containing essential amino acids not only exist in a balanced manner, but are also rich in proteins, lipids, sugars, vitamin B group, folic acid, and nicotine. A vitamin group such as acid or pantothenic acid, and a mineral such as zinc or selenium. The physiological activities and pharmacological effects of the bee are known to have antibacterial, anti-inflammatory, antiviral, antiprotozoal, and tinnitus-eliminating effects.

本發明之蜂子,係使用生蜂子及加工處理狀態之生蜂子。蜂子之加工處理,具體而言,係包含:粉碎之蜂子(生或乾燥物);乾燥之蜂子(生或粉碎物);加熱處理後之蜂子(生、乾燥物或粉碎物);使用水、含水乙醇等萃取蜂子所得之物。較佳地,可列舉為將蜂子(生)乾燥後、藉由粉碎而調製之蜂子的乾燥粉末。 The bee of the present invention uses raw bees and raw bees in a processed state. The processing of the bee, specifically, comprises: pulverized bees (raw or dried); dried bees (raw or pulverized); heated treated bees (raw, dried or pulverized) Extraction of bees using water, aqueous ethanol, or the like. Preferably, it is a dry powder of the bee prepared by pulverizing the bee (raw).

本發明之用語「蜂子」,若無特別註明,則包含:生蜂子、對於該蜂子施予乾燥、粉碎或加熱處理之加工物、以及使用水、含水乙醇等萃取蜂子(生、乾燥物及粉碎物)所得之物、以及使用蛋白分解酵素(肽酶)處理蜂子及其加工物所得之物。 The term "bee" according to the present invention includes, unless otherwise specified, a raw bee, a processed product which is dried, pulverized or heat-treated, and a bee is extracted using water, aqueous ethanol or the like (raw, The obtained product of the dried product and the pulverized material, and the obtained product obtained by treating the bee and its processed product with a proteolytic enzyme (peptidase).

乾燥方法,可使用一般食品加工所採用之習知的方法,如:通風乾燥、陽光乾燥等之自然乾燥、以電等加熱乾燥之強制乾燥、冷凍乾燥等。而較佳為冷凍乾燥。又,乾燥時間並無特別限制,可列舉例如,採 用通風、陽光乾燥等之自然乾燥的情況,約3天,而以電等加熱乾燥之強制乾燥的情況,在約50℃下進行約1~3天。通常,水分含量為10質量%以下,較佳係乾燥為5質量%以下。又,如通風、陽光乾燥等之自然乾燥的情形,水分含量較難為10質量%以下時,可在其後進一步使用冷凍乾燥機,進行使水分下降之處理。 The drying method may be a conventional method used in general food processing, such as natural drying such as air drying, sun drying, forced drying by electric heating or the like, freeze drying, or the like. It is preferably freeze-dried. Further, the drying time is not particularly limited, and for example, In the case of natural drying such as ventilation or drying in the sun for about 3 days, the forced drying by heating with electricity or the like is carried out at about 50 ° C for about 1 to 3 days. Usually, the water content is 10% by mass or less, and preferably the drying amount is 5% by mass or less. In the case of natural drying such as ventilation or drying, when the water content is difficult to be 10% by mass or less, the freeze dryer can be further used to carry out the treatment for lowering the water content.

粉碎處理(粉末化處理),可使用如:使用粉碎器(軋機)之方法;使用石臼將其碾碎之方法等習知的方法進行。 The pulverization treatment (pulverization treatment) can be carried out by a conventional method such as a method using a pulverizer (rolling mill) or a method of crushing it using a mortar.

加熱蜂子之方法,並無特別限制,可較佳列舉使用70~120℃之熱處理方法。可簡便地將蜂子(包含生、乾燥物及粉碎物)投入沸騰之水中進行加熱處理。為了儘量避免各種之維生素、胺基酸等有效成分溶出,加熱處理,可較佳使用蒸氣蒸蜂子之方法。 The method of heating the bees is not particularly limited, and a heat treatment method using 70 to 120 ° C is preferably used. The bees (including raw, dried and pulverized materials) can be easily put into boiling water for heat treatment. In order to avoid the dissolution of various active ingredients such as vitamins and amino acids as much as possible, and heat treatment, a method of steaming the bees may be preferably used.

萃取方法,可使用如下方法:對於蜂子(包含生、乾燥物及磨碎物)添加水、含水乙醇等,攪拌後,藉由離心得到上清液之方法;進行濾紙過濾得到濾液之方法等。 For the extraction method, the following method can be used: a method of adding water, aqueous ethanol, etc. to a bee (including raw, dried, and ground matter), stirring, and obtaining a supernatant by centrifugation; and filtering the filtrate to obtain a filtrate. .

藉由該蛋白質分解酵素處理,可使蜂子及其加工物所含蛋白質低分子化,從而得到一種對於由該蛋白質所導致的過敏反應,可加以抑制之酵素處理物(低過敏原化酵素處理物)。 By treating the proteolytic enzyme, the protein contained in the bee and its processed product can be reduced in molecular weight, thereby obtaining an allergic reaction caused by the protein, and the enzyme treatment can be suppressed (hypoallergenic enzyme treatment) ()).

對於蜂子及其加工物進行酵素處理所使用之蛋白質分解酵素,可適宜地列舉為肽酶。所使用之肽酶,只要具有內肽酶作用及外肽酶作用中至少一種作用即可。 The proteolytic enzyme used for the enzyme treatment of the bee and its processed material can be suitably enumerated as a peptidase. The peptidase to be used may have at least one of an endopeptidase action and an exopeptidase action.

至少具有內肽酶活性之蛋白質分解酵素,可列舉:源自動物(例如:胰蛋白酶、胰凝乳蛋白酶等)、源自植物(例如:木瓜蛋白酶等)、源 自微生物(例如:乳酸菌、酵母、黴菌、枯草桿菌、放線菌等)之內肽酶。 Examples of proteolytic enzymes having endopeptidase activity include animals derived from animals (eg, trypsin, chymotrypsin, etc.), plants (eg, papain, etc.), and sources. Endopeptidase from microorganisms (eg, lactic acid bacteria, yeast, mold, Bacillus subtilis, actinomycetes, etc.).

至少具有外肽酶活性之蛋白質分解酵素,可列舉:羧肽酶、胺基肽酶、或源自微生物(例如:乳酸菌、麴黴屬菌、根黴屬菌等)之外肽酶、或一併具有內肽酶活性之胰酶、胃蛋白酶等。 Examples of the proteolytic enzyme having exopeptidase activity include a carboxypeptidase, an aminopeptidase, or a peptidase derived from a microorganism (for example, lactic acid bacteria, pullulans, Rhizopus, etc.) or Trypsin, pepsin, etc. with endopeptidase activity.

如此之各種酵素內,具有外肽酶活性及內肽酶活性兩者之酵素的較佳例,可列舉:灰色鏈黴菌(Streptomyces griseus)所產肽酶(商品名:肌動蛋白酶AS)、米麴菌(Aspergillus oryzae)所產肽酶(商品名:蛋白酶A、風味蛋白酶)、蜂蜜麴黴(Aspergillus melleus)所產肽酶(商品名:蛋白酶P)等。 Preferred examples of the enzyme having both exopeptidase activity and endopeptidase activity in such various enzymes include peptidase produced by Streptomyces griseus (trade name: actinase AS) and rice. Peptidase (trade name: protease A, flavor protease) produced by Aspergillus oryzae, and peptidase (trade name: protease P) produced by Aspergillus melleus.

此外,具有外肽酶作用之酵素的較佳例,可列舉:米麴菌(Aspergillus oryzae)所產肽酶(商品名:鮮味酵素G、Promod192P、Promod194P、Sumizyme FLAP)、醬油麴黴(Aspergillus sojae)所產肽酶(商品名:Sternzym B15024)、麴黴屬所產肽酶(商品名:Kokulase P)、米根黴(Rhizopus oryzae)所產肽酶(商品名:肽酶R)等。 Further, preferred examples of the enzyme having an exopeptidase action include peptidase produced by Aspergillus oryzae (trade name: umami enzyme G, Promod 192P, Promod 194P, Sumizyme FLAP), and Aspergillus soygium (Aspergillus). The peptidase produced by sojae (trade name: Sternzym B15024), the peptidase produced by the genus Fusarium (trade name: Kokulase P), and the peptidase produced by Rhizopus oryzae (trade name: peptidase R).

進一步,具有內肽酶作用之肽酶的較佳例,可列舉:枯草桿菌(Bacillus subtilis)所產肽酶(商品名:orientase 22BF、Nukureishin)、地衣芽孢桿菌(Bacillus licheniformis)所產肽酶(商品名:鹼性蛋白酶)、嗜熱脂肪芽孢桿菌(Bacillus stearothermophilus)所產肽酶(商品名:蛋白酶S)、解澱粉芽孢桿菌(Bacillus amyloliquefaciens)所產肽酶(商品名:中性蛋白酶)、芽孢桿菌屬所產肽酶(商品名:Protamex)等。 Further, preferred examples of the peptidase having an endopeptidase action include peptidase produced by Bacillus subtilis (trade name: orientase 22BF, Nukureishin), and Bacillus licheniformis (pacillus licheniformis). Trade name: alkaline protease), peptidase produced by Bacillus stearothermophilus (trade name: protease S), peptidase produced by Bacillus amyloliquefaciens (trade name: neutral protease), Peptidase produced by Bacillus (trade name: Protamex) and the like.

為了減低蜂子及其加工物之過敏性的酵素處理,可例如,根據日本特開2009-159997號公報之記載進行。 In order to reduce the allergic enzyme treatment of the bee and its processed product, it can be carried out, for example, according to the description of JP-A-2009-159997.

本發明之強壯強精劑、性功能改善劑、男性更年期症狀改善 劑及抗疲勞劑,只要不阻礙本發明之效果,可包含追加之成分。包含相關追加之成分時,強壯強精劑、性功能改善劑、男性更年期症狀改善劑及抗疲勞劑中之蜂子的比例可例示為0.01~99質量%,較佳係1~80質量%,更佳係10~70質量%,進一步更佳係20~50質量%。 The strong and strong essence agent, sexual function improving agent and male menopausal symptom improvement of the invention The agent and the anti-fatigue agent may contain additional components as long as they do not inhibit the effects of the present invention. When the relevant additional ingredients are included, the ratio of the strong and strong sperm, the sexual function improving agent, the male menopausal symptom improving agent, and the anti-fatigue agent can be exemplified as 0.01 to 99% by mass, preferably 1 to 80% by mass. More preferably, it is 10 to 70% by mass, and further preferably 20 to 50% by mass.

本發明之強壯強精劑、性功能改善劑、男性更年期症狀改善劑及抗疲勞劑,其形態並無特別限定,可例如,粉末狀、顆粒狀、錠劑狀、膠囊狀、液狀、懸浮液狀、乳液狀等之製劑型態。 The form of the strong and strong essence agent, the sexual function improving agent, the male menopausal symptom improving agent and the anti-fatigue agent of the present invention is not particularly limited, and may be, for example, a powder, a granule, a tablet, a capsule, a liquid, or a suspension. A formulation form such as a liquid or emulsion.

本發明之強壯強精劑、性功能改善劑、男性更年期症狀改善劑及抗疲勞劑,可作為食品組成物、醫藥部外品及醫藥品(特別係,口服藥物)之成分,適當地使用。 The strong and strong agent, the sexual function improving agent, the male menopausal symptom improving agent, and the anti-fatigue agent of the present invention can be suitably used as a component of a food composition, a pharmaceutical product, and a pharmaceutical product (particularly, an oral drug).

本發明之強壯強精劑、性功能改善劑、男性更年期症狀改善劑及抗疲勞劑,其意義包含:保健、健康維持、增進等之目的之飲食品(例如,健康食品、功能性食品、營養組成物(nutritional composition)、營養補助食品、補充劑、保健用食品、特定保健用食品、營養功能食品、或功能性表示食品)、醫藥部外品及醫藥品(特別係,口服藥物)。此外,本發明之強壯強精劑、性功能改善劑、男性更年期症狀改善劑及抗疲勞劑,其意義亦包含:賦予強壮強精作用、性功能改善作用、男性更年期症狀改善作用、抗疲勞作用及提升活力作用之添加劑。 The strong and strong essence agent, the sexual function improving agent, the male menopausal symptom improving agent and the anti-fatigue agent of the present invention include foods and drinks for the purpose of health care, health maintenance, promotion, etc. (for example, health food, functional food, nutrition) Composition (nutritional composition), nutritional supplement foods, supplements, health foods, specific health foods, nutritious functional foods, or functional foods), pharmaceutical products, and pharmaceuticals (specially, oral drugs). In addition, the strong and strong essence agent, sexual function improving agent, male menopausal symptom improving agent and anti-fatigue agent of the invention also include: imparting strong and strong sperm function, improving sexual function, improving male menopausal symptoms, and anti-fatigue effect. And additives to enhance vitality.

上述之飲食品,因應必要,可配合賦形劑、光澤劑、礦物質類、維他命類、黃酮類、醌類、多酚類、胺基酸、核酸、必須脂肪酸、清涼劑、結合劑、甜味劑、崩解劑、潤滑劑、著色劑、香料、穩定劑、防腐劑、緩釋調整劑、界面活性劑、溶解劑、濕潤劑等。 The above food and beverage, if necessary, can be combined with excipients, brighteners, minerals, vitamins, flavonoids, terpenoids, polyphenols, amino acids, nucleic acids, essential fatty acids, cooling agents, binding agents, sweet Flavoring agents, disintegrating agents, lubricants, coloring agents, perfumes, stabilizers, preservatives, sustained release modifiers, surfactants, solubilizers, wetting agents, and the like.

上述之飲食品的種類,並無特別限定,可列舉例如,飲料類(咖啡、果汁、茶飲料之清涼飲料、乳飲料、乳酸菌飲料、優格飲料、碳酸飲料、日本酒、洋酒、果實種之酒等);抹醬類(卡士達奶油等);醬料類(水果果醬等);糕點類(巧克力、甜甜圈、派、泡芙、口香糖、果凍、糖果、餅乾、蛋糕、布丁等);日式點心類(大福、餅、饅頭、卡斯提拉、餡蜜、羊羹等);冷凍甜點類(冰淇淋、冰棒、雪寶等);食品類(咖哩、牛丼、雜炊、味噌湯、湯、肉醬、義大利麵、醬菜、果醬等);調味料類(調味汁、撒入米飯混食的料、增味劑、湯塊等)等。 The type of the above-mentioned foods and drinks is not particularly limited, and examples thereof include beverages (coffee, juice, refreshing drinks for tea drinks, milk drinks, lactic acid bacteria drinks, yogurt drinks, carbonated drinks, Japanese sake, wine, fruit wine). Etc.); sauces (casta cream, etc.); sauces (fruit jams, etc.); cakes (chocolate, donuts, pies, puffs, chewing gum, jellies, candies, biscuits, cakes, puddings, etc.) Japanese dim sum (Dafu, cake, taro, Casita, stuffed honey, lamb, etc.); frozen desserts (ice cream, popsicle, Xuebao, etc.); food (curry, burdock, chowder, miso soup) , soup, meat sauce, Italian noodles, pickles, jams, etc.); seasonings (sauce, mixed with rice, flavorants, soups, etc.).

作為補充劑使用時之劑量單位形式並無特別限定,可適當地作選擇,可列舉例如,錠劑、膠囊劑、顆粒劑、液劑、散劑等。 The dosage unit form when used as a supplement is not particularly limited, and may be appropriately selected, and examples thereof include a tablet, a capsule, a granule, a liquid, a powder, and the like.

上述之飲食品所含蜂子的比例,可列舉例如為0.01~99質量%,較佳係1~80質量%,更佳係10~70質量%,進一步更佳係20~50質量%之濃度。 The proportion of the bee contained in the above-mentioned foods and drinks may be, for example, 0.01 to 99% by mass, preferably 1 to 80% by mass, more preferably 10 to 70% by mass, still more preferably 20 to 50% by mass. .

上述之飲食品的攝取量,可因應攝取者之體重、年齡、性別、症狀等之種種條件進行適當地設定。 The intake of the above-mentioned foods and drinks can be appropriately set depending on various conditions such as the weight, age, sex, and symptoms of the ingested person.

本發明之強壯強精劑、性功能改善劑、男性更年期症狀改善劑及抗疲勞劑,作為醫藥部外品或醫藥品調製時,可稱為蜂子製劑。醫藥部外品或醫藥品,可使用單體之上述蜂子,亦可混合維他命、生藥等日本藥局所記載之其他醫藥成分使用。 The strong and strong agent, the sexual function improving agent, the male menopausal symptom improving agent, and the anti-fatigue agent of the present invention can be referred to as a bee preparation when prepared as a pharmaceutical product or a pharmaceutical product. For the external medicines or pharmaceuticals of the Ministry of Medicine, the above-mentioned bees may be used alone, or other pharmaceutical ingredients described in the Japanese Pharmacopoeia such as vitamins and crude drugs may be mixed.

本發明之強壯強精劑、性功能改善劑、男性更年期症狀改善劑及抗疲勞劑,作為醫藥部外品或醫藥品調製時,可將蜂子與醫藥品可容許之無毒性的載體、稀釋劑或賦形劑,一同調製為片劑(包含素錠、糖衣 錠、發泡錠、膜包片錠、咀嚼錠、口服錠)、膠囊劑、丸劑、粉末劑(散劑)、細粒劑、顆粒劑、液劑、懸浮液、乳濁液、糖漿、糊漿等之型態,成為可口服之製劑。 The strong and strong agent, the sexual function improving agent, the male menopausal symptom improving agent and the anti-fatigue agent of the present invention can be used as a non-toxic carrier and diluted by the bee and the pharmaceutical product when being prepared as a pharmaceutical product or a pharmaceutical product. Or an excipient, together with a tablet (including a tablet, a sugar coating) Ingots, foamed ingots, film-coated tablets, chewable tablets, oral tablets, capsules, pills, powders (granules), fine granules, granules, liquids, suspensions, emulsions, syrups, syrups The type of the drug becomes an orally administrable preparation.

上述之醫藥部外品或醫藥品的劑量,可根據患者之體重、年齡、性別、症狀等之種種條件進行適當地設定,理想上,一天之蜂子可為0.5g以上,較佳係0.7g以上,更佳係1g以上。 The dosage of the above-mentioned medical product or the pharmaceutical product can be appropriately set according to various conditions such as the weight, age, sex, and symptoms of the patient. Ideally, the bee of one day can be 0.5 g or more, preferably 0.7 g. More preferably, it is 1 g or more.

上述之醫藥部外品或醫藥品所含蜂子的比例,只要能奏效本發明之效果,則並無特別限制,可列舉例如0.01~99質量%,較佳係1~80質量%,更佳係10~70質量%,進一步更佳係20~50質量%之濃度。 The ratio of the bee contained in the pharmaceutical product or the pharmaceutical product is not particularly limited as long as it can exert the effects of the present invention, and is, for example, 0.01 to 99% by mass, preferably 1 to 80% by mass, more preferably It is 10 to 70% by mass, and more preferably 20 to 50% by mass.

以上說明的本發明之強壯強精劑、性功能改善劑、男性更年期症狀改善劑及抗疲勞劑,係適用於包含人類之哺乳動物(較佳係人類,特別係男性)者。 The strong and strong sizing agent, sexual function improving agent, male climacteric symptom improving agent and anti-fatigue agent of the present invention described above are suitable for use in mammals including humans (preferably humans, particularly males).

本發明之飲食品、醫藥部外品及醫藥品,具有強壯強精作用、性功能改善作用、男性更年期症狀之改善作用、抗疲勞作用及提升活力作用。此外,由於本發明之飲食品、醫藥部外品及醫藥品,並不會使雄激素上升,故有高安全性。 The food and beverage, the external medicine and the pharmaceutical product of the invention have the functions of strengthening and strengthening the sperm, improving the sexual function, improving the menopausal symptoms of the male, anti-fatigue effect and enhancing the vitality. Further, since the foods and drinks, the medical products, and the pharmaceuticals of the present invention do not increase the androgen, they have high safety.

【實施例】[Examples]

以下,藉由實施例進一步詳細說明本發明。惟,本發明並非限定為此等實施例。 Hereinafter, the present invention will be described in further detail by way of examples. However, the invention is not limited to the embodiments.

[試驗例] [Test example]

<受試者> <subject>

進行問卷調查及檢查(健康檢查、醫生問診、血液檢查、問卷調查等),分別為(1)35歲以上60歲以下之男性、(2)男性更年期問診表(以下AMS)中27點以上49點以下者、(3)游離睪固酮為8.5pg/mL以上未達11.8pg/mL者、(4)已婚或有異性對象者,共11名受試者。 Questionnaires and examinations (health examinations, doctor consultations, blood tests, questionnaires, etc.) are (1) men over the age of 35 and under 60 years old, and (2) male menopause consultation forms (below AMS) 27 points or more 49 The following points, (3) free steroids were 8.5pg/mL or more and less than 11.8pg/mL, (4) married or heterosexual subjects, a total of 11 subjects.

<試驗方法> <Test method>

受試者11名,在12週內連續每天攝取軟膠囊形狀之蜂子含有食品膠囊6粒,其中1粒膠囊含有蜂子180mg。受試食品膠囊1粒之營養成分如下表所示。 The subject was 11 people, and the soft capsule-shaped bees contained in the 12-week continuous daily contain 6 food capsules, one of which contained 180 mg of bee. The nutrients of one capsule of the test food capsule are shown in the table below.

又,受試者從試驗開始日之1週前至攝取結束,每天記錄包含早晨勃起的有無之自覺症狀、生活訊息等。 Further, the subject recorded the symptoms including the presence or absence of morning erection, life information, and the like from 1 week before the start of the test to the end of the ingestion.

試驗開始時及攝取開始後第12週,進行醫生診察、問卷調查、健康檢查、血液檢查及尿液檢查,評估總睪固酮(以下簡稱TT)、游離睪固酮(以下簡稱FT)、增齡男性症狀調査票(以下簡稱AMS)、抑鬱自評量表(Self-rating depression scale,以下簡稱SDS)、國際勃起功能指標量表簡易版(以下簡稱IIEF5)及疲勞感VAS。此外,試驗期間中之早晨勃起次數亦為評估 項目。 At the beginning of the trial and at the 12th week after the start of the trial, doctors' examinations, questionnaires, health examinations, blood tests, and urine tests were performed to evaluate total steroids (hereinafter referred to as TT), free steroids (hereinafter referred to as FT), and aging men's symptoms. Ticket (hereinafter referred to as AMS), Self-rating depression scale (SDS), International Erectile Function Scale Scale (hereinafter referred to as IIEF5) and fatigue sensation VAS. In addition, the number of morning erections during the trial period was also assessed. project.

AMS分數係在LOH症候群之症狀問診中被廣泛使用之自己記入式之問卷,其構成係分為心理因素5項目(25點)、身體因素7項目(35點)、性功能因素5項目(25點)之合計17項目(85點)。各項目皆由「無」、「輕微」、「普通」、「嚴重」、「非常嚴重」之5階段評估,個別以1~5點之點數評分。分數越高則表示症狀越嚴重。 The AMS score is a self-reported questionnaire widely used in the symptomatic consultation of LOH syndrome. The composition is divided into psychological factors 5 items (25 points), physical factors 7 items (35 points), and sexual function factors 5 items (25). Point) Total 17 items (85 points). All items are "none", "slight", "normal" and "serious" The "very serious" 5-stage assessment is scored individually by 1 to 5 points. The higher the score, the more severe the symptoms.

SDS係表示抑鬱狀態程度之指標,抑鬱症狀由20個質問項目所成。分數越高則表示症狀越嚴重。 The SDS system is an indicator of the degree of depression, and the depressive symptoms are formed by 20 questions. The higher the score, the more severe the symptoms.

IIEF5係將國際勃起功能指標量表(International Index of Erectile Function,以下簡稱IIEF)分為5項目所成簡略化者,其係使用於ED之篩選及治療之効果判定的國際性指標。分數越低則表示症狀越嚴重。 The IIEF5 series is divided into five items by the International Index of Erectile Function (IIEF), which is an international indicator used for screening and treatment of ED effects. The lower the score, the more severe the symptoms.

疲勞感係根據VAS法,將10cm之直線的左端作為「從沒經驗過之完全不會感到疲勞的最佳感覺」;右端作為「從沒經驗過之疲勞至完全無法行動的最差感覺」,在直線上之該位置紀錄×號,其係將左端至所紀錄之位置的距離數值化者,數值降低時表示改善了疲勞。 According to the VAS method, the left end of the straight line of 10cm is "the best feeling that you will never feel tired from the experience without experience"; the right end is "the worst feeling from the fatigue you have never experienced to the total inability to act". The position X is recorded at the position on the straight line, which is the value of the distance from the left end to the recorded position. When the value is lowered, the fatigue is improved.

<統計分析> <Statistical Analysis>

求得每組各資料之平均值及標準差,將AMS分數、IIEF5、SDS、早晨勃起次數及疲勞感VAS進行Wilcoxon之位數差異檢定。 The mean and standard deviation of each group of data were obtained, and the difference in the number of Wilcoxon digits was determined by AMS score, IIEF5, SDS, morning erection times and fatigue sensation VAS.

TT、FT、健康檢查、血液檢查及血液生化檢查,係進行對應之t檢定。 TT, FT, health check, blood test and blood biochemical test, the corresponding t test.

任一者之統計分析法皆使用雙尾檢定,危險率為5%及1%。 The statistical analysis of either method uses a two-tailed test with a hazard rate of 5% and 1%.

<結果> <Result>

1 有效性評估項目 1 Effectiveness assessment project

1)AMS 1) AMS

AMS分數,與攝取開始時進行比較,可發明攝取結束時之「合計」(圖1-a)「性因素」(圖1-b)「身體因素」(圖1-c)有意義之下降。 The AMS score, when compared to the start of ingestion, can be invented at the end of the intake (Figure 1-a) "Sexual Factors" (Figure 1-b) "Physical Factors" (Figure 1-c).

2)IIEF5 2) IIEF5

試驗食品攝取前後之比較中,可發現IIEF5在攝取結束時有意義之增加(圖2)。 A comparison of the pre- and post-intake of the test foods revealed a significant increase in IIEF5 at the end of ingestion (Figure 2).

3)早晨勃起次數 3) Morning erection times

試驗食品攝取前後之比較中,可發現早晨勃起次數在攝取結束時有意義之增加(圖3)。 In the comparison before and after the test food intake, it was found that the number of morning erections increased meaningfully at the end of the intake (Fig. 3).

4)疲勞感VAS 4) Fatigue VAS

試驗食品攝取前後之比較中,可發現疲勞感在攝取結束時有意義之下降(圖4)。 In the comparison before and after the test food intake, it was found that the sense of fatigue was meaningfully decreased at the end of the intake (Fig. 4).

5)SDS 5) SDS

試驗食品攝取前後之比較中,可發現抑鬱症狀在攝取結束時有意義之下降(圖5)。 In the comparison before and after the test food intake, it was found that the depressive symptoms were meaningfully decreased at the end of the intake (Fig. 5).

2 安全性評估項目 2 Safety assessment project

確認每位受試者之TT及FT(圖6)、健康檢查、血液檢查、血液生化檢查及尿液檢查,並無發現臨床上問題之變動。 Confirmation of TT and FT (Figure 6), health check, blood test, blood biochemical test and urine test for each subject did not reveal any clinical changes.

試驗期間中,受試者並無發現自覺症狀。此外,攝取期間進行之診察,亦無發現任何與有害現象相當者。 During the test period, the subjects did not find any symptoms. In addition, during the ingestion period, no abnormalities were found.

<結論> < Conclusion>

日常生活中活力不足之35歲以上60歳以下的男性11名,1日攝取6粒之含蜂子食品的軟膠囊連續12週時,AMS有意義下降、IIEF5及早晨勃起次數有意義增加、對於疲勞評估之VAS及SDS問卷調查可發現有意義下降。另一方面,總及游離睪固酮值並無變化。亦即,蜂子不會使睪固酮值上升,且發現其具有男性更年期症狀之改善效果、抗疲勞效果、及抗壓效果。 11 people with less than 35 years of age and 60 years of vitality in daily life, and 6 capsules of soft capsules containing bee food on the 1st, a meaningful decline in AMS, meaningful increase in IIEF5 and morning erections, fatigue assessment The VAS and SDS questionnaires found a meaningful decline. On the other hand, there was no change in total free ketamine values. That is, the bee does not increase the value of the testosterone, and it is found to have an improvement effect on male menopausal symptoms, an anti-fatigue effect, and a compression-resistance effect.

處方例 Prescription example

以下,表示本發明之處方例。 Hereinafter, a typical example of the present invention will be described.

處方例1 軟膠囊劑 Prescription Example 1 Soft capsule

1080mg之1/6量的蜂子,加上食用油脂、蜂蠟、及大豆植物衍生卵磷脂,並填充至含有明膠及焦糖色素的軟膠囊中,得到軟膠囊製劑。 1/6 of the amount of bees of 1080 mg, plus edible fats, beeswax, and soybean plant-derived lecithin, and filled into soft capsules containing gelatin and caramel color to obtain a soft capsule preparation.

處方例2 軟膠囊劑 Prescription Example 2 Soft capsule

180mg之蜂子,與食用油脂、γ-胺基丁酸、甘油、大豆植物衍生卵磷脂、蜂蠟、維他命B2、及維他命B12混合,並填充至含有明膠及焦糖色素的軟膠囊中,得到軟膠囊製劑。 180mg of bee, mixed with edible oils, γ-aminobutyric acid, glycerin, soybean plant-derived lecithin, beeswax, vitamin B2, and vitamin B12, and filled into soft capsules containing gelatin and caramel color to obtain soft Capsule preparation.

處方例3 軟膠囊劑 Prescription Example 3 Soft capsule

100mg之蜂子,與食用油脂、瑪卡萃取物粉末、東葛阿里萃取物粉末、冬蟲夏草菌絲體粉末、含鋅酵母、蓽拔萃取物粉末、蜂蠟、及大豆植物衍生卵磷脂混合,並填充至含有明膠及可可色素的軟膠囊中,得到軟膠囊製劑。 100mg of bee, mixed with edible fat, maca extract powder, Dongge Ali extract powder, Cordyceps sinensis mycelium powder, zinc-containing yeast, sputum extract powder, beeswax, and soybean plant-derived lecithin To a soft capsule containing gelatin and cocoa pigment, a soft capsule preparation is obtained.

Claims (4)

一種含有蜂子的強壯強精劑。 A strong and strong agent containing bees. 一種含有蜂子的性功能改善劑。 A sexual function improving agent containing bees. 一種含有蜂子的男性更年期症狀改善劑。 A male menopausal symptom improving agent containing bees. 一種含有蜂子的抗疲勞劑。 An anti-fatigue agent containing bees.
TW105111807A 2015-04-17 2016-04-15 Nutrient tonic containing bee larvae TW201642882A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015085118 2015-04-17

Publications (1)

Publication Number Publication Date
TW201642882A true TW201642882A (en) 2016-12-16

Family

ID=57126769

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105111807A TW201642882A (en) 2015-04-17 2016-04-15 Nutrient tonic containing bee larvae

Country Status (5)

Country Link
JP (1) JP6483244B2 (en)
CN (1) CN107427538A (en)
SG (1) SG11201708300YA (en)
TW (1) TW201642882A (en)
WO (1) WO2016167254A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102334546B1 (en) * 2019-12-10 2021-12-03 대한민국 Composition for anti-inflammatory comprising male pupa extract

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
ITRM20020620A1 (en) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti USE OF CARNITINE FOR THE PREVENTION AND / OR TREATMENT OF DISORDERS CAUSED BY ANDROPAUSE.
JP2005179307A (en) * 2003-12-22 2005-07-07 Lion Corp Climacterium syndrome treating agent and medicinal preparation containing the same
JP2007024822A (en) * 2005-07-21 2007-02-01 Aska Pharmaceutical Co Ltd Discriminating method of male menopause or depression
JP4526467B2 (en) * 2005-10-26 2010-08-18 アサヒビール株式会社 Nourishing tonic beverage
CN101036722A (en) * 2006-03-15 2007-09-19 张丽英 Health-caring food for easing and improving climacteric Syndrome of men and the preparation thereof
ES2861583T3 (en) * 2007-10-10 2021-10-06 Kyowa Hakko Bio Co Ltd Rapid-acting oral preparation that can increase the level of arginine in the blood and comprises citrulline and arginine
RU2376978C2 (en) * 2007-12-29 2009-12-27 Валентин Васильевич Хижа Complex api preparation in form of suppositories for treatment of andrological diseases and method of obtaining it
JP4917584B2 (en) * 2008-06-23 2012-04-18 アピ株式会社 Processed solubilized bees, method for producing the same, antioxidant, ACE inhibitor, antihypertensive agent, dermal fibroblast proliferation promoter, fatigue recovery agent, blood flow improving agent, and solubilized bees Pharmaceuticals, cosmetics or food / drinks contained
JP2009159997A (en) * 2009-04-27 2009-07-23 Yamada Bee Farm Corp Food composition containing bee larva of lowered molecular weight and production method thereof
CN102134545B (en) * 2010-12-10 2012-06-27 黄淑辉 Bee pupa prepared wine and preparation method thereof
CN103750094B (en) * 2013-06-29 2015-09-30 明光市昊昊蜂业有限公司 Male hachinoko health-care paste and preparation method thereof

Also Published As

Publication number Publication date
CN107427538A (en) 2017-12-01
JP6483244B2 (en) 2019-03-13
JPWO2016167254A1 (en) 2018-01-11
WO2016167254A1 (en) 2016-10-20
SG11201708300YA (en) 2017-11-29

Similar Documents

Publication Publication Date Title
JP6596024B2 (en) Composition
CN111989111B (en) Sleep-promoting composition, and pharmaceutical composition, food and drink composition using same
JP2000247878A (en) Theanine-containing composition
JP4917584B2 (en) Processed solubilized bees, method for producing the same, antioxidant, ACE inhibitor, antihypertensive agent, dermal fibroblast proliferation promoter, fatigue recovery agent, blood flow improving agent, and solubilized bees Pharmaceuticals, cosmetics or food / drinks contained
JP7176813B2 (en) Composition for improving fatigue
JP6483244B2 (en) Nourishing tonic containing bee cub
JP6787595B2 (en) Blood flow improver, royal jelly composition and method for producing royal jelly composition
JP4673071B2 (en) Iron-adsorptive polymer substance, iron-containing polymer substance, and production method thereof
JP6782381B1 (en) Food composition for improving brain function, brain function improving agent, food composition for increasing brain-derived neurotrophic factor, food composition for suppressing stress hormone secretion, brain-derived neurotrophic factor increasing agent and stress hormone secretion inhibitor
JP6981641B2 (en) PDE5 activity inhibitor
JP2017088549A (en) Endurance enhancers
JP2009084191A (en) Pharmaceutical composition for inhibiting appetite
JP6514502B2 (en) Feeling improvement agent
JP6514500B2 (en) Arthralgia and back pain improving agents
JP7423731B2 (en) Agents to improve fatigue, lack of motivation, or drowsiness
JP6717509B2 (en) Dizziness improver
JP2003277273A (en) Mineral absorption-promoting agent
JP6873452B2 (en) Food composition
JP6514499B2 (en) Chest pain remedy
JP6514501B2 (en) Skin itching remedy
JP6537887B2 (en) Vertigo improving agent
JP2004210728A (en) Anti-stress agent
TW201701889A (en) Urinary system symptom amelioration agent
JP2022074486A (en) Sarcopenia improver
JP2022099458A (en) Glucagon-like peptide-1 secretion promoting composition